410 related articles for article (PubMed ID: 28276205)
1. Pediatric langerhans cell histiocytosis: single center experience over a 17-year period.
İnce D; Demirağ B; Özek G; Erbay A; Ortaç R; Oymak Y; Kamer S; Yaman Y; Kundak S; Vergin C
Turk J Pediatr; 2016; 58(4):349-355. PubMed ID: 28276205
[TBL] [Abstract][Full Text] [Related]
2. Langerhans cell histiocytosis of the temporal bone: A review of 29 cases at a single center.
Modest MC; Garcia JJ; Arndt CS; Carlson ML
Laryngoscope; 2016 Aug; 126(8):1899-904. PubMed ID: 26535795
[TBL] [Abstract][Full Text] [Related]
3. [Clinical study of 131 children with multi-system Langerhans cell histiocytosis].
Wu FF; Gao YJ; Pan C; Chen J; Tang JY
Zhonghua Er Ke Za Zhi; 2016 May; 54(5):349-53. PubMed ID: 27143076
[TBL] [Abstract][Full Text] [Related]
4. Craniofacial involvement in Langerhans cell histiocytosis: A review of 44 cases at a single medical center.
Lin TE; Chu YY; Chang TY; Liao HT
J Plast Reconstr Aesthet Surg; 2023 Jul; 82():12-20. PubMed ID: 37148805
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary Langerhans cell histiocytosis: a variable disease in childhood.
Odame I; Li P; Lau L; Doda W; Noseworthy M; Babyn P; Weitzman S
Pediatr Blood Cancer; 2006 Dec; 47(7):889-93. PubMed ID: 16276522
[TBL] [Abstract][Full Text] [Related]
6. [Langerhans cell histiocytosis in children: clinicopathological and ultrastructural analyses of 345 cases].
Yao XF; Wang X; Wang L; Fu LB; Zhang N; Zhang M; He LJ
Zhonghua Bing Li Xue Za Zhi; 2019 Jan; 48(1):17-21. PubMed ID: 30641640
[No Abstract] [Full Text] [Related]
7. Treatment of multisystem Langerhans cell histiocytosis. Results of the DAL-HX 83 and DAL-HX 90 studies. DAL-HX Study Group.
Minkov M; Grois N; Heitger A; Pötschger U; Westermeier T; Gadner H
Klin Padiatr; 2000; 212(4):139-44. PubMed ID: 10994540
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of children with multiple system Langerhans cell histiocytosis by Japan Langerhans Cell Histiocytosis Study Group Protocol].
Huang JB; Xue HM; Chen YY; Huang K
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):146-9. PubMed ID: 23484709
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes and prognostic risk factors of Langerhans cell histiocytosis in children: Results from the BCH-LCH 2014 protocol study.
Cui L; Wang CJ; Lian HY; Zhang L; Ma HH; Wang D; Chen FF; Zhang Q; Yang Y; Wei A; Huang XT; Zhu T; Wang TY; Li ZG; Zhang R
Am J Hematol; 2023 Apr; 98(4):598-607. PubMed ID: 36594188
[TBL] [Abstract][Full Text] [Related]
10. The influence of clinical features mimicking primary immunodeficiency diseases (mPID) on children with Langerhans cell histiocytosis (LCH) - Four with mPID among 39 LCH children from one referral center during 18-year period.
Lin SC; Lee WI; Jaing TH; Yang CP; Hung IJ; Chang TY; Huang JL; Chen LC; Ou LS; Yao TC; Chen SH
Immunobiology; 2020 Mar; 225(2):151877. PubMed ID: 31862125
[TBL] [Abstract][Full Text] [Related]
11. Additive Prognostic Impact of Gastrointestinal Involvement in Severe Multisystem Langerhans Cell Histiocytosis.
Minkov M; Pötschger U; Thacker N; Astigarraga I; Braier J; Donadieu J; Henter JI; Lehrnbecher T; Rodriguez-Galindo C; Sieni E; Nanduri V; van den Bos C; Abla O;
J Pediatr; 2021 Oct; 237():65-70.e3. PubMed ID: 34146548
[TBL] [Abstract][Full Text] [Related]
12. Langerhans cell histiocytosis of the cervical spine: a single Chinese institution experience with thirty cases.
Jiang L; Liu ZJ; Liu XG; Zhong WQ; Ma QJ; Wei F; Dang GT; Yuan HS
Spine (Phila Pa 1976); 2010 Jan; 35(1):E8-15. PubMed ID: 20042947
[TBL] [Abstract][Full Text] [Related]
13. Clinical features and treatment outcomes of liver involvement in paediatric Langerhans cell histiocytosis.
Ge X; Ou W; Wei A; Lian H; Ma H; Cui L; Wang D; Zhang L; Wang X; He L; Zhang R; Wang T
BMC Pediatr; 2024 May; 24(1):316. PubMed ID: 38714959
[TBL] [Abstract][Full Text] [Related]
14. Intensification of induction therapy and prolongation of maintenance therapy did not improve the outcome of pediatric Langerhans cell histiocytosis with single-system multifocal bone lesions: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study.
Morimoto A; Shioda Y; Imamura T; Kudo K; Kitoh T; Kawaguchi H; Goto H; Kosaka Y; Tsunematsu Y; Imashuku S;
Int J Hematol; 2018 Aug; 108(2):192-198. PubMed ID: 29594922
[TBL] [Abstract][Full Text] [Related]
15. Clinical Analysis of 122 Cases of Langerhans Cell Histiocytosis.
Wang T; Su B; Han D; Tong A; Li J; Liu Y; Jin H; Fang K
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Apr; 39(2):206-210. PubMed ID: 28483018
[TBL] [Abstract][Full Text] [Related]
16. Treatment outcomes and prognostic factors of patients with adult Langerhans cell histiocytosis.
Cao XX; Duan MH; Zhao AL; Cai H; Chen J; Gao XM; Liu T; Cai HC; Zhang L; Sun J; Liang ZY; Zhou DB; Li J
Am J Hematol; 2022 Feb; 97(2):203-208. PubMed ID: 34797941
[TBL] [Abstract][Full Text] [Related]
17. Differentiating skin-limited and multisystem Langerhans cell histiocytosis.
Simko SJ; Garmezy B; Abhyankar H; Lupo PJ; Chakraborty R; Lim KP; Shih A; Hicks MJ; Wright TS; Levy ML; McClain KL; Allen CE
J Pediatr; 2014 Nov; 165(5):990-6. PubMed ID: 25441388
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics and treatment outcome of Langerhans cell histiocytosis: 22 years' experience of 154 patients at a single center.
Lee JW; Shin HY; Kang HJ; Kim H; Park JD; Park KD; Kim HS; Park SH; Wang KC; Ahn HS
Pediatr Hematol Oncol; 2014 Apr; 31(3):293-302. PubMed ID: 24397251
[TBL] [Abstract][Full Text] [Related]
19. Clinical features and treatment outcomes of Langerhans cell histiocytosis of the spine.
Xu X; Han S; Jiang L; Yang S; Liu X; Yuan H; Wei F; Wu F; Dang L; Zhou H; Zhang H; Liu Z
Spine J; 2018 Oct; 18(10):1755-1762. PubMed ID: 29505854
[TBL] [Abstract][Full Text] [Related]
20. Langerhans' cell histiocytosis: head and neck manifestations in children.
Quraishi MS; Blayney AW; Walker D; Breatnach FB; Bradley PJ
Head Neck; 1995; 17(3):226-31. PubMed ID: 7782207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
